Publications

5802 Results

Doxorubicin-cisplatin-vinblastine combination chemotherapyof advanced endometrial carcinoma: A Southwest Oncology Group Phase IItrial.

Authors
DS Alberts;NL Mason;RV O'Toole;RD Hilgers;SE Rivkin;JG Boutselis;RP Pugh;VK Vaitkevicius;JB Green;N Oishi
Journal / Conference
Gyn Onc 26:193-201
Year
1987
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8103

Phase II evaluation of bisantrene hydrochloride in refractorymalignant melanoma. A Southwest Oncology Group study.

Authors
DS Alberts;N Mason-Liddil;SJ Green;JD Cowan;WS Fletcher;B Neilan;JT Guy;RB Epstein
Journal / Conference
Invest New Drugs 5:289-292
Year
1987
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8118

Phase II trial of bisantrene in hepatocellular carcinoma: ASouthwest Oncology Group Study.

Authors
TD Brown;TR Fleming;RA Shildt;JD Cowan
Journal / Conference
Cancer Treat Rep 71(11):1101-1102
Year
1987
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8119

A phase II trial of vinblastine in patients with advanced orrecurrent endometrial carcinoma: A Southwest Oncology Group study.

Authors
JT Thigpen;R Kronmal;S Vogel;HE Hynes;W Nahhas;RJ Belt;SP Balcerzak;RB Epstein;JJ Costanzi
Journal / Conference
JCO 10(5):429-431
Year
1987
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8200

Phase II study of spirogermanium in advanced adenocarcinoma ofthe prostate: A Southwest Oncology Group study.

Authors
JH Saiers;B Blumenstein;M Slavik;JJ Costanzi;ED Crawford
Journal / Conference
Cancer Treat Rep 71(12):1305-1306
Year
1987
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8217

Therapy of advanced renal cell cancer with spiro-germanium.

Authors
JH Saiers;M Slavik;RL Stephens;ED Crawford
Journal / Conference
Cancer Treat Rep 71(2):207-208
Year
1987
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8218

Preoperative radiation therapy in the treatment of bladdercancer.

Authors
ED Crawford;S Das;JA Smith, Jr
Journal / Conference
Urol Clinics of North Am 14(4):781-787
Year
1987
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8221 (INT-0007)

Phase II trial of spirogermanium in central nervous systemtumors: A Southwest Oncology Group Study.

Authors
JW Goodwin;J Crowley;B Tranum;R Vance;M Slavik;S Balcerzak;D Hacker
Journal / Conference
Cancer Treat Rep 71(1):99-100
Year
1987
Research Committee(s)
Brain
Study Number(s)
SWOG-8239

Phase II evaluation of spirogermanium in malignant melanoma: ASouthwest Oncology Group study.

Authors
JW Goodwin;K Kopecky;M Slavik;BL Tranum;SP Balcerzak;WS Fletcher;JJ Costanzi
Journal / Conference
Cancer Treat Rep 71(10):985-986
Year
1987
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8240

Short-term chemotherapy of poor-prognosis metastatic breastcancer with three non-cross resistant chemotherapy regimens: ASouthwest Oncology Group study.

Authors
FR Ahmann;R Pugh
Journal / Conference
Cancer 59(2):239-244
Year
1987
Research Committee(s)
Breast
Study Number(s)
SWOG-8278